Claude Shelton

447 citations
7 papers · 331 indexed · h-index 6
Topics
Muscle Physiology and Disorders (3 papers)Protein Degradation and Inhibitors (3 papers)Multiple Myeloma Research and Treatments (2 papers)

In The Last Decade

Claude Shelton

7 papers receiving 330 citations

Peers

Claude Shelton
Comparison fields: 5 of 49
  • Molecular Biology 275
  • Cell Biology 83
  • Hematology 64
  • Oncology 33
  • Cardiology and Cardiovascular Medicine 21
Replace Anna Reister Schultz with:
Anna Reister Schultz United States
Lisa M. Privette Vinnedge United States
Paola A. Bignone United Kingdom
Pavlína Janovská Czechia
Dongmin Gu United States
Taiko Sukezane Japan
Bettina Maier Germany
Elisa Agnese Nigro Italy
Carissa Dege United States
Manjula Nagala United Kingdom
Claude Shelton relative to Anna Reister Schultz United States Anna Reister Schultz's profile →
Citations per field
00.5×7.8×
Anna Reister Schultz · 1×
Citations per year

Countries citing papers authored by Claude Shelton

Since Specialization
Citations

This map shows the geographic impact of Claude Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Shelton more than expected).

Fields of papers citing papers by Claude Shelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Shelton. The network helps show where Claude Shelton may publish in the future.

Co-authorship network of co-authors of Claude Shelton

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Shelton. A scholar is included among the top collaborators of Claude Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Shelton. Claude Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 3
2 25
3 25
4 143
5 14
6 58
7 63

About Claude Shelton

Claude Shelton is a scholar working on Hematology, Cell Biology and Molecular Biology, having authored 7 papers that have together received 331 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (3 papers), Protein Degradation and Inhibitors (3 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (64 citations), Cell Biology (83 citations) and Aging (8 citations). Claude Shelton has collaborated with scholars based in United States, Switzerland and Russia. Frequent co-authors include Susan M. Abmayr, Shufei Zhuang, James S. Duncan, Kelly Duncan, Jonathan Chernoff, Alison Kurimchak, Heather Cartwright, Lauren S. Fink, Wayne E. Childers and Magid Abou‐Gharbia. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026